Solving Controlled Release Drug Delivery Challenges Using Extrusion-Spheronization

Extrusion Spheronization’s Expanding Influence as a Drug Manufacturing Driver

Widely acknowledged as a predictable vehicle for the control, distribution and transportation of therapeutic agents around the body, E-S engineered formulations make a variety of common and emerging controlled release dose forms possible. These include fixed-dose combinations (FDCs), combined, modified release single-capsule forms and emerging multi-unit particulate system (MUPS) tablet designs.

Download Whitepaper

Please share this content with others who may benefit from it.
You may also be interested in

Get the industry insights you care about

Join 3000+ subscribers and receive BORA resources in your inbox.

Resources by Category